ScanSource, Inc. filings document the reporting obligations of a Nasdaq-listed technology distributor with common stock traded under SCSC. Recent Form 8-K disclosures cover quarterly and fiscal-year operating results, earnings exhibits, Regulation FD materials, executive appointments, board leadership updates and changes in the company’s independent registered public accounting firm.
The company’s proxy materials provide governance and shareholder-meeting disclosures, while periodic reporting referenced in its earnings filings frames results against annual and quarterly reports. These records center on operating performance, financial presentation, corporate governance, auditor oversight and the capital-market status of ScanSource common stock.
ScanSource, Inc. (SCSC) officer Shana C Smith reported a proposed sale of 13,858 common shares, with an aggregate market value of $645,197.08 and an approximate sale date of November 19, 2026. Merrill Lynch is named as broker. The notice lists 20,325,050 common shares outstanding. The acquisition table describes prior acquisitions as vesting of restricted stock unit awards and performance share unit awards granted under the issuer’s equity compensation plan.
ScanSource, Inc. (SCSC) was the subject of a joint Schedule 13G reporting by American Century Investment Management, Inc., American Century Companies, Inc. and Stowers Institute for Medical Research. Each reported beneficial ownership of 1,032,015 shares, equal to 5.1% of the common stock, and sole voting and dispositive power over that amount; each reported zero shared voting and dispositive power. The three filers reported the same position, not separate amounts to be added together.
ScanSource, Inc. reported $962.3 million in net sales for the quarter ended September 30, 2026, up 30.1% from $739.7 million a year earlier. Operating income fell 52.2% to $12.4 million, net income was $8.7 million versus $19.9 million, and diluted earnings per share were $0.42 versus $0.89. Gross profit rose 8.8% to $116.9 million, while gross margin was 12.2%, compared with 14.5%.
The company completed its MicroAge acquisition on September 1, 2026. MicroAge contributed $20.0 million of net sales and $0.6 million of net income after acquisition; the latter included $1.2 million of intangible-asset amortization. MicroAge's initial cash purchase price was $248.2 million, with $30.5 million of acquired cash and $217.8 million net cash paid initially. ScanSource used $42.3 million in operating cash flow, versus $23.2 million provided a year earlier, and paid $217.8 million for business acquisitions, net of acquired cash. At September 30, debt totaled $332.4 million, including $231.9 million borrowed under its revolving credit facility; $168.1 million was available for additional borrowings.
ScanSource, Inc. reported first-quarter fiscal 2027 net sales of $962.3 million, up 30.1% year over year, and gross profit of $116.9 million, up 8.8%. Gross margin was 12.2%, versus 14.5% a year earlier. GAAP net income fell to $8.7 million from $19.9 million, and diluted EPS was $0.42 versus $0.89; adjusted EBITDA declined to $31.3 million from $38.6 million. Higher bad debt expense of approximately $4.5 million reduced diluted EPS by approximately $0.16.
ScanSource completed its MicroAge acquisition on September 1, 2026. MicroAge serves a diversified U.S. base of approximately 2,400 clients, has more than 200 employees and is included in Intelisys & Solution Services. For FY2027, ScanSource raised its outlook to net sales of $3.8 billion to $4.0 billion and adjusted EBITDA of $175 million to $185 million; free cash flow is expected to be at least $85 million. In the quarter, ScanSource used $42.3 million of operating cash flow and $44.1 million of free cash flow, primarily reflecting working capital investments to support growth.
Vanguard Capital Management reported beneficial ownership of 1,013,314 shares of ScanSource, Inc. (SCSC) common stock, equal to 5.03% of the class. The reported position includes securities attributed to Vanguard Capital Management LLC and specified affiliates or business divisions, including funds and client accounts over which those units exercise dispositive and/or voting power.
Vanguard reported sole dispositive power over 1,013,314 shares and sole voting power over 152,921 shares; shared voting and dispositive power were each zero. Vanguard Capital Management, including registered investment companies and other managed accounts, has the right to receive or direct dividends or sale proceeds; no other person's interest was more than 5%.
ScanSource, Inc. is asking shareholders to elect seven directors, approve named executive officer compensation on an advisory basis, and ratify Deloitte & Touche LLP’s appointment as auditor for the fiscal year ending June 30, 2027, at its December 8, 2026 annual meeting. Shareholders of record on October 2, 2026 may vote; 20,367,768 common shares were outstanding and entitled to vote on that date, with one vote per share.
Fiscal 2026 net sales increased 6.1% to $3.23 billion, gross profit increased 7.0% to $437.4 million, and adjusted EBITDA increased 4.8% to $151.5 million. GAAP net income was $78.9 million, while non-GAAP net income increased 8.0% to $91.9 million and non-GAAP diluted EPS increased 18.8% to $4.24. ScanSource repurchased $97.9 million of shares. The say-on-pay vote is non-binding. Peter C. Browning retired from the Board in August 2026, and Charles A. Mathis serves as Lead Independent Director. The company said it contacted shareholders representing nearly 70% of shares outstanding and held calls with shareholders representing approximately 60%.
ScanSource, Inc. reported that Pzena Investment Management, LLC beneficially owned 941,150 shares of its common stock, or 4.7% of the class, as of September 30, 2026. Pzena reported sole voting power over 672,998 shares and sole dispositive power over 941,150 shares, with no shared voting or dispositive power. Its clients have the right to receive dividends and sale proceeds from the reported securities; no one client’s interest relates to more than 5% of the class.
Wasatch Advisors reported beneficial ownership of 841,300 shares of ScanSource, Inc. (SCSC) common stock, or 4.2%, as of September 30, 2026. It reported sole voting power over 521,631 shares and sole dispositive power over 841,300 shares, with no shared voting or dispositive power. The amendment identifies ownership of 5% or less of the class.
SCANSOURCE, INC. (SCSC) received a notice that officer Michael L. Baur plans to sell restricted securities under Rule 144. The planned transaction covers 19,980 shares of common stock, arising from the exercise of employee stock options, through a broker assisted cashless sale dated September 10, 2026.
The filing lists an aggregate market value of $1,109,823.29 for these shares and shows 20,142,812 shares outstanding as of September 10, 2026. This amendment resubmits a prior notice with an updated number of outstanding shares.